Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.

Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- Check5 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoChange DetectedThere are additions of four update dates: 2026-02-25, 2027-08-02, 2026-02-12, and 2026-02. It also shows deletions of four dates: 2026-02-04, 2026-09-30, 2026-01-15, and 2026-01.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a new publication reference: PAPILLON Asia subgroup analysis in Lung Cancer (2026) with DOI 10.1016/j.lungcan.2026.109302.SummaryDifference0.0%

- Check34 days agoChange DetectedAdministrative site updates were applied, including Revision: v3.4.2 and new date stamps (2026-02-04, 2026-01-15, 2026-01). A site-wide government funding status notice banner was removed.SummaryDifference0.2%

- Check41 days agoChange DetectedA notice about a lapse in government funding and the NIH Clinical Center's status was added to the page. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a glossary display and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0). Removed or renamed older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.